Method of treatment of fibrotic lesions by topical administration of lathyrogenic drugs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4485088
SERIAL NO

06362241

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure deals with a method of treating fibrotic lesions related to abnormal collagen polymerization by topical administration of lathyrogenic substances, such as .beta.-aminopropionitrile fumarate, aminoacetonitrile, D-penicillamine, into the site of the injury. The lathyrogenic drugs are administered by local injection or onto the skin and percutaneously transported into the site of the lesion. Lathyrogens, administered locally as a single drug or in combination do not produce any local or systemic toxic effects and are improving the function of the pathological fibrosis based on the accumulation of polymerized collagenous protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LATHROTEC INC A CORP OF ARIZONA1500 N WILMOT ROAD SUITE 290 TUCSON AS 85712

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chvapil, Milos Tucson, AZ 15 1515

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation